Log In
Print
BCIQ
Print
Print this Print this
 

mGluR2 NAM

  Manage Alerts
Collapse Summary General Information
Company Domain Therapeutics S.A.
DescriptionNegative allosteric modulator of metabotropic glutamate receptor subtype 2 (mGluR2)
Molecular Target Metabotropic glutamate receptor subtype 2 (mGluR2) (GRM2)
Mechanism of ActionMetabotropic glutamate receptor subtype 2 (mGluR2) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today